BPG is committed to discovery and dissemination of knowledge
Citation
Lu J, Xie ZY, Zhu DH, Li LJ. Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature. World J Clin Cases 2021; 9(7): 1705-1713 [PMID: 33728315 DOI: 10.12998/wjcc.v9.i7.1705]
Please LOGIN to submit a new comment.